Atlas Trials

CellSeed Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch CellSeed Inc.

RecordFirmDate
A Phase III Study of CLS2901C in Patients With Osteoarthritis of the Knee (NCT06549686)CellSeed Inc.2023-10-20
A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group (NCT04689594)CellSeed Inc.2021-02-04
Human (Autologous) Oral Mucosal Cell Sheet Transplantation After ESD in Patients With Superficial Esophageal Cancer (NCT02866019)CellSeed Inc.2016-04-01

Track CellSeed Inc. automatically

Every clearance here is in the API, with alerts when new ones post.